From
StayCurrentMD
LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Jul 2024 · 1 min read
In brief
In brief
This research investigates the molecular mechanisms underlying biliary atresia, focusing on how long noncoding RNA MEG9 contributes to inflammation and liver fibrosis through S100A9 protein interactions. The study advances understanding of BA pathogenesis and may inform future therapeutic targets for this pediatric cholestatic liver disease.
Written by the GCMD Library team from the article.
The pathogenesis of biliary atresia (BA) remains elusive. We aimed to investigate the role of long noncoding RNA (lncRNA) MEG9 in BA.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
The disproportionate burden of severe obesity in youth with special needs and the role of metabolic and bariatric surgery
Published Jun 2026
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Article
Type of pledget and suture technique relative to esophageal tensile strength in long-gap esophageal atresia
Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026